19 results for author:"Pelosi G." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene. Pelosi G., Gasparini P., Cavazza A., Rossi G., Graziano P., Barbareschi M., Perrone F., Barberis M., Takagi M., Kunimura T. et al. Lung Cancer 77:507-514(2012) · Mapped (18) |
| p40 (DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Bishop J.A., Teruya-Feldstein J., Westra W.H., Pelosi G., Travis W.D., Rekhtman N. Mod. Pathol. 25:405-415(2012) · Mapped (8) |
| Optimizing pemetrexed-gemcitabine combination in patients with advanced non-small cell lung cancer: a pharmacogenetic approach. De Pas T.M., Toffalorio F., Giovannetti E., Radice D., Russo F., Angeli I., Calamai G., Spitaleri G., Catania C., Noberasco C. et al. J Thorac Oncol 6:768-773(2011) · Mapped (9) |
| Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors. Cui T., Hurtig M., Elgue G., Li S.C., Veronesi G., Essaghir A., Demoulin J.B., Pelosi G., Alimohammadi M., Oberg K. et al. PLoS ONE 5:e16010-e16010(2010) · Mapped (2) |
| Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. Righi L., Volante M., Rapa I., Tavaglione V., Inzani F., Pelosi G., Papotti M. Endocr. Relat. Cancer 17:977-987(2010) · Mapped (5) |
| Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia. Bonanni B., Serrano D., Gandini S., Guerrieri-Gonzaga A., Johansson H., Macis D., Cazzaniga M., Luini A., Cassano E., Oldani S. et al. Clin. Cancer Res. 15:7053-7060(2009) · Mapped (18) |
| Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. Righi L., Volante M., Tavaglione V., Bille A., Daniele L., Angusti T., Inzani F., Pelosi G., Rindi G., Papotti M. Ann. Oncol. 21:548-555(2010) · Mapped (2) |
| Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung. Monica V., Ceppi P., Righi L., Tavaglione V., Volante M., Pelosi G., Scagliotti G.V., Papotti M. Mod. Pathol. 22:709-717(2009) · Mapped (3) |
| Erlotinib combined with cyclosporine in a liver-transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer. De Pas T., Spitaleri G., Pelosi G., De Carlis L., Lorizzo K., Locatelli M., Curigliano G., Toffalorio F., Catania C., de Braud F. J Thorac Oncol 4:138-139(2009) · Mapped (19) |
| Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. Marchetti A., Felicioni L., Pelosi G., Del Grammastro M., Fumagalli C., Sciarrotta M., Malatesta S., Chella A., Barassi F., Mucilli F. et al. |
| Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib. Curigliano G., Pelosi G., De Pas T., Renne G., De Cobelli O., Manzotti M., Spitaleri G., de Braud F. Prostate 67:603-604(2007) · Mapped (19) |
| Expression of p63 in thymomas and normal thymus. Dotto J., Pelosi G., Rosai J. Am. J. Clin. Pathol. 127:415-420(2007) · Mapped (4) |
| CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients. Pelosi G., Barisella M., Pasini F., Leon M.E., Veronesi G., Spaggiari L., Fraggetta F., Iannucci A., Masullo M., Sonzogni A. et al. Mod. Pathol. 17:711-721(2004) · Mapped (7) |
| Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma. Zerbini A., Pilli M., Soliani P., Ziegler S., Pelosi G., Orlandini A., Cavallo C., Uggeri J., Scandroglio R., Crafa P. et al. J. Hepatol. 40:102-109(2004) · Mapped (7) |
| Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Pelosi G., Pastorino U., Pasini F., Maissoneuve P., Fraggetta F., Iannucci A., Sonzogni A., De Manzoni G., Terzi A., Durante E. et al. Br. J. Cancer 88:537-547(2003) · Mapped (4) |
| Progesterone receptor immunoreactivity in minute meningothelioid nodules of the lung. Pelosi G., Maffini F., Decarli N., Viale G. Virchows Arch. 440:543-546(2002) · Mapped (10) |
| Structure solution and molecular dynamics refinement of the yeast Cu,Zn enzyme superoxide dismutase. Djinovic K., Gatti G., Coda A., Antolini L., Pelosi G., Desideri A., Falconi M., Marmocchi F., Rotilio G., Bolognesi M. Acta Crystallogr. B 47:918-927(1991) · UniProtKB (1) |
| Crystal structure solution and refinement of the semisynthetic cobalt-substituted bovine erythrocyte superoxide dismutase at 2.0-A resolution. Djinovic K., Coda A., Antolini L., Pelosi G., Desideri A., Falconi M., Rotilio G., Bolognesi M. J. Mol. Biol. 226:227-238(1992) · UniProtKB (1) |
| Crystal structure of yeast Cu,Zn superoxide dismutase. Crystallographic refinement at 2.5-A resolution. Djinovic K., Gatti G., Coda A., Antolini L., Pelosi G., Desideri A., Falconi M., Marmocchi F., Rotilio G., Bolognesi M. J. Mol. Biol. 225:791-809(1992) · UniProtKB (1) |